Testing effectiveness (Phase 2)Study completedNCT02806284What this trial is testingPneumococci and Hib Vaccination After Neurotrauma or NeurosurgeryWho this might be right forMeningitis Uppsala University 85
Testing effectiveness (Phase 2)Study completedNCT00129116What this trial is testing3 Formulations of Hib-MenCY-TT Vaccine & 1 Formulation of Hib-MenC-TT Vaccine Compared to Licensed Meningococcal Serogroup C Conjugate Vaccine, Each Administered at 2,3,4 Mths of AgeWho this might be right forHaemophilus Influenzae Type bNeisseria Meningitidis GlaxoSmithKline 388
Large-scale testing (Phase 3)Study completedNCT01983540What this trial is testingAntibody Persistence at Age 3.5 and 4.5 Years After Primary and Booster DTaP-IPV-Hep B-PRP~T or Infanrix Hexa VaccinationWho this might be right forDiphtheriaTetanusWhooping Cough+3 more Sanofi Pasteur, a Sanofi Company 558
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06618196What this trial is testingStudy to Evaluate the Immunogenicity of LR20062 Compared to Control When Administered Intramuscularly in Healthy Infants At 2, 4, 6 Months of AgeWho this might be right forDiphtheriaTetanusPertussis+3 more LG Chem 336
Large-scale testing (Phase 3)WithdrawnNCT03128489What this trial is testingEvaluation of Immunogenicity and Safety of DTPa-IPV/Hib Conjugate Vaccine (Infanrix™-IPV/Hib) Administered at 6, 10 and 14 Weeks in Healthy Indian InfantsWho this might be right forDiphtheriaAcellular PertussisHaemophilus Influenzae Type b+2 more GlaxoSmithKline
Large-scale testing (Phase 3)Study completedNCT00473668What this trial is testingNon-inferiority of GSK Biologicals' DTPw-HBV/Hib Compared to Two Formulations of GSK Biologicals' DTPw-HBV/HibWho this might be right forWhole Cell PertussisHaemophilus Influenzae Type bTetanus+2 more GlaxoSmithKline 300
Large-scale testing (Phase 3)Study completedNCT00345683What this trial is testingSafety of Hib-MenCY-TT Vaccine Versus Licensed Hib Conjugate Vaccine, Given at 12 to 15 Months of Age.Who this might be right forHaemophilus Influenzae Type bNeisseria Meningitidis GlaxoSmithKline 4,021
Testing effectiveness (Phase 2)Study completedNCT00551629What this trial is testingTest the Safety and Effectiveness of an Investigational Vaccine in Infants (V419-002)Who this might be right forBacterial Infections; Virus Diseases Merck Sharp & Dohme LLC 708
Post-approval studies (Phase 4)Study completedNCT02853929What this trial is testingEvaluation of Immunogenicity and Safety of a Booster Dose of Infanrix Hexa™ in Healthy Infants Born to Mothers Vaccinated With Boostrix™ During Pregnancy or Immediately Post-deliveryWho this might be right forDiphtheriaHepatitis BAcellular Pertussis+4 more GlaxoSmithKline 551
Large-scale testing (Phase 3)Study completedNCT00880477What this trial is testingImmunogenicity and Safety of Primary and Booster Vaccination With DTPa-HBV-IPV/Hib VaccineWho this might be right forHepatitis B GlaxoSmithKline 140
Testing effectiveness (Phase 2)Study completedNCT01061541What this trial is testingImmunogenicity, Safety & Reactogenicity of GSK Vaccine Tritanrix™-HepB/Hib2.5 Compared to GSK Vaccine Tritanrix™-HepB/Hiberix™Who this might be right forHaemophilus Influenzae Type b GlaxoSmithKline 192
Large-scale testing (Phase 3)Study completedNCT01226953What this trial is testingImmunogenicity and Safety of a Booster Dose of Monovalent Glycoprotein-Conjugated (Diptheria Toxin -CRM197) Hib Vaccine in 365-569 Days Old Healthy InfantsWho this might be right forHaemophilus Influenzae Type b (Hib) Infection Novartis Vaccines 660
Post-approval studies (Phase 4)Study completedNCT00197782What this trial is testingThe Immediate and Longterm Immune Responses of UK Infants and Young Children to a Booster Dose of Hib VaccineWho this might be right forHaemophilus Influenzae Type b Public Health England
Testing effectiveness (Phase 2)Study completedNCT00307567What this trial is testingMulticentre Booster & Immune Memory Study of a Booster Dose of GSK Biologicals' 10-valent Pneumococcal Conjugate Vaccine or a Single Dose of 23-valent Plain Polysaccharide Vaccine in Healthy Children Aged 11-18 Mths, Previously Vaccinated in Study 103488Who this might be right forAcellular PertussisTetanusHepatitis B+3 more GlaxoSmithKline 689
Large-scale testing (Phase 3)Study completedNCT00831753What this trial is testingStudy of DTaP-IPV-Hep B-PRP~T Combined Vaccine Compared to Infanrix®Hexa in Healthy Peruvian InfantsWho this might be right forDiphtheriaTetanusPertussis+2 more Sanofi Pasteur, a Sanofi Company 263
Post-approval studies (Phase 4)Study completedNCT00503165What this trial is testingA Phase IV Study to Evaluate the Immunogenicity and Safety in UK Laboratory Workers of MenitorixWho this might be right forVaccination Public Health England 30
Large-scale testing (Phase 3)Study completedNCT00327184What this trial is testingPrimary & Booster Study in Infants to Demonstrate Non-inferiority, Persistence & Immunogenicity of Hib-MenC VaccineWho this might be right forNeisseria MeningitidisHaemophilus Influenzae Type b GlaxoSmithKline 709
Large-scale testing (Phase 3)Study completedNCT01457560What this trial is testingImmunogenicity and Reactogenicity of DTPa-HBV-IPV/Hib Vaccine Followed by the Same Vaccine and Oral Polio VaccineWho this might be right forHepatitis BAcellular PertussisHaemophilus Influenzae Type b+3 more GlaxoSmithKline 80
Post-approval studies (Phase 4)UnknownNCT00877357What this trial is testingSafety, Long Term Immunogenicity and Lot Consistency Study of Liquid Pentavalent Combination VaccineWho this might be right forDiphtheriaTetanusPertussis+2 more Shantha Biotechnics Limited 3,000
Not applicableStudy completedNCT00661401What this trial is testingSpecific IgG Antibody in Patients With Primary Antibody Deficiencies Treated With Subcutaneous ImmunoglobulinWho this might be right forCommon Variable ImmunodeficiencyAgammaglobulinemia Federal University of São Paulo 5